They found that EGFR ex20 ins-positive NSCLCs with high TMB, which is more common in smoking-associated cases, had a higher response rate to ICIs, potentially due to increased T-cell activity against neoantigens generated by tumor mutations. This evidence concerns the gene EGFR and neoplasm.